Free Trial
NASDAQ:MASS

908 Devices (MASS) Stock Price, News & Analysis

908 Devices logo
$2.56 -0.18 (-6.57%)
(As of 11/22/2024 ET)

About 908 Devices Stock (NASDAQ:MASS)

Key Stats

Today's Range
$2.55
$2.74
50-Day Range
$2.34
$3.91
52-Week Range
$2.19
$12.51
Volume
210,506 shs
Average Volume
367,700 shs
Market Capitalization
$89.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Moderate Buy

Company Overview

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

908 Devices Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
52nd Percentile Overall Score

MASS MarketRank™: 

908 Devices scored higher than 52% of companies evaluated by MarketBeat, and ranked 515th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    908 Devices has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    908 Devices has only been the subject of 3 research reports in the past 90 days.

  • Read more about 908 Devices' stock forecast and price target.
  • Earnings Growth

    Earnings for 908 Devices are expected to grow in the coming year, from ($1.75) to ($1.20) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 908 Devices is -1.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 908 Devices is -1.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    908 Devices has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about 908 Devices' valuation and earnings.
  • Percentage of Shares Shorted

    5.69% of the float of 908 Devices has been sold short.
  • Short Interest Ratio / Days to Cover

    908 Devices has a short interest ratio ("days to cover") of 8.3.
  • Change versus previous month

    Short interest in 908 Devices has recently increased by 5.84%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    908 Devices does not currently pay a dividend.

  • Dividend Growth

    908 Devices does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.69% of the float of 908 Devices has been sold short.
  • Short Interest Ratio / Days to Cover

    908 Devices has a short interest ratio ("days to cover") of 8.3.
  • Change versus previous month

    Short interest in 908 Devices has recently increased by 5.84%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    908 Devices has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for 908 Devices this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    2 people have added 908 Devices to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, 908 Devices insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    27.70% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    88.06% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about 908 Devices' insider trading history.
Receive MASS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter.

MASS Stock News Headlines

908 Devices FY2024 EPS Forecast Lowered by Leerink Partnrs
908 Devices FY2024 EPS Forecast Boosted by William Blair
When it comes to NVDA… “acceleration cycles” are the key
Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.
Boston firm to shift manufacturing to North Carolina
908 Devices downgraded to Market Perform from Outperform at Leerink
See More Headlines

MASS Stock Analysis - Frequently Asked Questions

908 Devices' stock was trading at $11.22 at the beginning of the year. Since then, MASS stock has decreased by 77.2% and is now trading at $2.56.
View the best growth stocks for 2024 here
.

908 Devices Inc. (NASDAQ:MASS) posted its quarterly earnings data on Tuesday, April, 30th. The company reported ($0.33) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.36) by $0.03. 908 Devices's quarterly revenue was up 5.3% on a year-over-year basis.

908 Devices (MASS) raised $101 million in an IPO on Friday, December 18th 2020. The company issued 6,300,000 shares at $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO.

Top institutional investors of 908 Devices include ARK Investment Management LLC (9.29%), Fred Alger Management LLC (2.37%), Geode Capital Management LLC (1.63%) and State Street Corp (1.38%). Insiders that own company stock include Christopher D Brown, Kevin J Knopp, Joseph H Iv Griffith, Trent A Basarsky, Mark Spoto, Michael S Turner and John Kenneweg.
View institutional ownership trends
.

Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that 908 Devices investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
4/30/2024
Today
11/23/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/04/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Measuring & controlling devices, not elsewhere classified
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:MASS
Fax
N/A
Employees
60
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$14.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+212.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-36,400,000.00
Net Margins
-109.11%
Pretax Margin
-109.59%

Debt

Sales & Book Value

Annual Sales
$50.23 million
Book Value
$3.76 per share

Miscellaneous

Free Float
25,177,000
Market Cap
$89.14 million
Optionable
Optionable
Beta
0.98
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (NASDAQ:MASS) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners